Recently, it has been demonstrated that secretion of TGF-β by tumour-associated reactive astrocytes from GBM with a transcriptional phenotype linked to the JAK/STAT pathway may modulate the tumour microenvironment to become immunosuppressive [41]. This evidence concerns the gene TGFB1 and glioblastoma.